| Crohn Disease |
1 |
1 |
| Colitis |
0 |
0.61 |
| Massachusetts |
0 |
0.49 |
| Arthritis |
0 |
0.25 |
| Refractory |
0 |
0.25 |
| Remission |
0 |
0.25 |
| Inflammatory Bowel Disease |
0 |
0.19 |
| Upper Respiratory Tract Infection |
0 |
0.17 |
| Adverse Effects |
0 |
0.12 |
| Anemia |
0 |
0.12 |
| Ankylosing Spondylitis |
0 |
0.12 |
| Clinical Research |
0 |
0.12 |
| Colonoscopy |
0 |
0.12 |
| Cyclosporine |
0 |
0.12 |
| Europe |
0 |
0.12 |
| Fever |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| Respiratory Tract |
0 |
0.12 |
| Thrombosis |
0 |
0.12 |
| Tumor |
0 |
0.12 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.11 |
| Otolaryngology |
0 |
0.1 |
| Acne |
0 |
0.09 |
| Psoriatic Arthritis |
0 |
0.08 |
| Rheumatoid Arthritis |
0 |
0.08 |
| Patient Safety |
0 |
0.06 |